Inhibrx Biosciences Inc.
Support and Resistance Levels
Past performance
News About INBX
All events for INBX
All deals for INBX
Financial Ratios
Financial Statements
INBX vs Sector & Peers
About Inhibrx Biosciences Inc.
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA. Website inhibrx.com
Headquarters La Jolla, CA, US